<DOC>
	<DOCNO>NCT00172523</DOCNO>
	<brief_summary>The purpose study elucidate significance adipocytokine woman PCOS among adiposity , hyperandrogenism insulin resistance .</brief_summary>
	<brief_title>Metabolic Disorders Polycystic Ovarian Syndrome</brief_title>
	<detailed_description>Polycystic ovary syndrome ( PCOS ) common endocrinopathy woman reproductive age probable prevalence 5 % 10 % . PCOS characterize chronic anovulation , menstrual irregularity , evidence hyperandrogenism ( either clinical , manifest hirsutism , acne , male pattern balding , biochemical , manifest elevated serum adrenal and/or ovarian androgen concentration ) . Fifty percent patient PCOS obese , presence obesity affect clinical manifestation PCOS . The underlie pathogenic mechanism appear involve insulin resistance hyperinsulinemia , magnitude great obese non-obese woman PCOS .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<criteria>1 . Oligomenorrhea ( less 6 time spontaneous MC per year ) Amenorrhea . 2 . Hyperandrogenism ( either clinical biochemistry . 3 . PCO ultrasound . 4.After menarche , menopause . 1. hormone therapy past 6 month . 2 . Pregnancy past 6 month 3.Acute illness find past 3 month . 4.Systemic disease include autoimmune disease , malignancy , hepatic , renal CVS disease , ever receive chemotherapy immunosuppressive agent .</criteria>
	<gender>Female</gender>
	<minimum_age>17 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>October 2004</verification_date>
</DOC>